ARID1A and central nervous system cancer: To further elucidate the underlying mechanisms, we compared the alterations in cell cycle and DNA damage repair proteins associated with wild‐type ARID1A, ARID1A KD, and ARID1A‐P16 deletion models to those in control glioma lines, following treatment with 200 μM TMZ, using Western blotting.